This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): doxazosin mesylate
Description: CARDURA is a quinazoline compound that is a selective inhibitor of thealpha1 subtype of alpha adrenergic receptors. In the human prostate, CARDURA antagonizes phenylephrine (alpha1 agonist)-induced contractions, in vitro, and binds with high affinity to the alpha1c adrenoceptor.
Pink Sheet Pfizer Cardura XL “Approvable”
Pink Sheet Pfizer Cardura XL “approvable” letter
Pink Sheet Pfizer/Andrx Cardura XL "approvable"
Additional information available to subscribers only: